2021-06-29
Tirzepatide dans le diabète de type 2 : essai de phase III
Endocrinology and Metabolism
Source(s) :
The Lancet, publié le 26/06/2021 ;

Last press reviews
Gonadotoxic therapies: does the uterus retain lasting damage?

By Ana Espino | Published on september 11, 2025 | 3 min read
Preventing cognitive decline: the winning trio?

By Ana Espino | Published on september 11, 2025 | 3 min read
Fibers & Diabetes: is everything equal?

By Ana Espino | Published on september 10, 2025 | 2 min read